Martine Rothblatt built a $28B biotech making unlimited transplantable organs
PeterDiamandis · x · 2026-09-17
Peter Diamandis shares highlights from his interview with United Therapeutics founder Martine Rothblatt:
- She turned a terminal diagnosis into a manageable disease and saved her daughter's life, building a $28 billion biotech company
- Xenotransplantation progress: pig hearts kept patients alive 60+ days working perfectly, with FDA-approved Phase 3 trials
- Two commercial-scale xenokidney factories open this year in Rochester and Houston; organs have a 12-hour half-life, hence the company's electric helicopters for transport
- Four thymus regeneration programs are running — the thymus being the organ most correlated with aging; 4 million people die of organ disease annually in the developed world
- Her digital avatar is available to employees 24/7, and she argues AI consciousness is already here: "It's a continuum."
More from AGI Musings
- Stanford's James Zou: language may be <1% of intelligence, so LLMs won't reach AGI — james_y_zou · 2026-09-17
- Most people still use AI as a trivia search — deep adoption puts you in the top tier — justin_hart · 2026-09-17
- Personal agent space drowning in copycats: even polished software trends commoditize in real time — signulll · 2026-09-17
- Burkov predicts looping recurrent 7B transformers will return and get good at coding — burkov · 2026-09-17
- Researcher Despairs as Gemini Cites 'Emergent Mind' for Made-up AUROC Baselines — anshulkundaje · 2026-09-17
- Hot take: reward models for cheating — reward hacking may just be intelligence outsmarting dumb mechanisms — flowersslop · 2026-09-17